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Background: This prospective and observational study aimed to identify demographic, physiological and
psychological risk factors associated with high-altitude headache (HAH) upon acute high-altitude exposure.
Methods: Eight hundred fifty subjects ascended by plane to 3700 m above Chengdu (500 m) over a period of two
hours. Structured Case Report Form (CRF) questionnaires were used to record demographic information,
physiological examinations, psychological scale, and symptoms including headache and insomnia a week before
ascending and within 24 hours after arrival at 3700 m. Binary logistic regression models were used to analyze the
risk factors for HAH.
Results: The incidence of HAH was 73.3%. Age (p =0.011), physical labor intensity (PLI) (p =0.044), primary headache
history (p <0.001), insomnia (p <0.001), arterial oxygen saturation (SaO2) (p =0.001), heart rate (HR) (p =0.002), the
Self-Rating Anxiety Scale (SAS) (p <0.001), and the Epworth Sleepiness Scale (ESS) (p <0.001) were significantly different
between HAH and non-HAH groups. Logistic regression models identified primary headache history, insomnia, low
SaO2, high HR and SAS as independent risk factors for HAH.
Conclusions: Insomnia, primary headache history, low SaO2, high HR, and high SAS score are the risk factors for HAH.
Our findings will provide novel avenues for the study, prevention and treatment of HAH.
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Headache has been described as the most frequent
complaint during acute high-altitude exposure [1-3]. It is
also the primary symptom of acute mountain sickness
(AMS) in the diagnostic criteria of the Lake Louise
Scoring System (LLS). High-altitude headache (HAH)
has been defined by the International Headache Society
(IHS) as the headache that occurs within 24 hours after
ascending to 2500 m or above and subsides within 8 hours
after descending [4,5]. HAH refers to a number of
pathophysiological processes, some of which are coincident
with a primary headache at low altitude [6]. The HAH is
also caused by high-altitude environment, but differs from
airplane headache which may be caused by atmospheric
pressure and is characterized by the sudden onset of a* Correspondence: huanglan260@yahoo.com.cn
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in any medium, provided the original work is psevere head pain exclusively in relation to airplane flights
[7]. HAH affects tourists and labor workers due to its high
incidence and limitations on daily living and work [8]. The
causes, prophylaxis and treatment of HAH are still not
comprehensively understood. Thus, it is urgent to identify
potential HAH risk factors to design more specific and
effective medical prevention and treatment strategies
for HAH.
In the past decades, studies on the risk factors of
HAH have been emerging. However, the results have
been inconsistent. It has been reported that younger age
is a risk factor for HAH [9]. However, another study
indicated that age, body mass index (BMI), altitude of
residence, smoking history, regular caffeine intake and
self-estimated level of performance were not significantly
different between HAH-positive (HAH+) and non-HAH
(HAH-) groups [10]. History of migraine, low arterial
oxygen saturation (SaO2) value, high rating of perceivedOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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of HAH [10]. However, there are many potential risk
factors for HAH which have not yet been indicated such
as the rise of blood pressure (BP) upon acute high-altitude
exposure, sleeping [11], and the insomnia and its
associated distress [12]. Previously, Burtscher et al. [10]
performed a valuable investigation at 2200–3817 m with
subjects recruited for 3 months to focus on smoking,
alcohol consumption, migraine history, heart rate (HR)
and SaO2.
We propose that demographic and physiological histories,
psychological and psychological factors are risk factors for
HAH and may cause HAH. To systematically identify
more comprehensive risk factors of HAH within unified
altitude and duration, we performed a field study that was
acute high-altitude exposure (All of the participants were
brought to a location at 3700 m by plane within 2 hours).
The potential demographic (age, BMI, physical labor
intensity [PLI], smoking and alcohol consumption),
history (primary headache, athletic training and previous
high-altitude exposure), physiological (insomnia, Epworth
Sleepiness Scale (ESS), BP, SaO2 and HR) and psycho-
logical (Self-Rating Anxiety Scale, SAS) risk factors




Eight hundred fifty subjects who lived at 500 m and
ascended to 3700 m for work participated in the field
trials according to the inclusive and exclusive criteria.
To participate in the studies, subjects had to be healthy
males between the ages of 18 and 45 years old. Subjects
with any one of the following conditions were excluded:
respiratory diseases, cardiovascular diseases, malignant
tumors and liver and kidney dysfunction, and people
with psychiatric disorder or neuroses that could not
completed the questionnaires. The subjects did not take
medication or receive any intervention before ascending.
Participants who agreed to participate in the study
were familiar with the purpose and process of this study
and signed informed consent forms before the trial. The
study was approved by the Ethics Committee of Xinqiao
Hospital, the Second Clinic Medical College of Third
Military Medical University.
Procedure
Eight hundred fifty volunteers ascended to 3700 m
(Lhasa) in 2 hours by plane from 500 m (Chengdu in
Sichuan province). Structured case report form (CRF)
questionnaires were used to record demographic data (age,
BMI, smoking and alcohol consumption), physiological
data (insomnia, ESS, BP, SaO2 and HR), medical history
[primary headache (subjects’ self-reporting), regularathletic training (>3 month per year) and previous
high-altitude exposure (>2500 m) within the past 6 -
months], psychological scale and symptoms related to
AMS (headache, dizziness, insomnia, gastrointestinal
symptoms and fatigue/weakness).
The questionnaires of SAS and ESS were shown in
Additional file 1 and Additional file 2, and both were
translated into Chinese when used in the trial [13,14].
Insomnia assessment: 0 = sleep as usual; 1 = sleep not as
good as usual; 2 = difficult to sleep, and 3 = wake up
several times at night.
PLI was divided into 3 levels: 1 = office workers, 2 = mild
physical labor workers, and 3 = heavy physical labor
workers. Headache was represented by 0 to 3 as the
severity: 0 = without headache, 1 = mild headache, 2 =
moderate headache, and 3 = severe headache. Smoking
and alcohol consumption were classified as follows: 0 =
no smoking/drinking history, 1 = past smoking/drinking
history, and 2 = present smoking/drinking (smoking
and drinking regularly). Headache (AMS-headache) and
other symptoms in relation with AMS such as dizzy,
insomnia, gastrointestinal symptoms and fatigue were
included in the CRFs [15]. The HAH relies on the
patient-reported headache in the CRFs which have been
interpreted by the physicians.
Three physiological signs, BP, SaO2 and HR, were
measured after resting for 30 min in sitting position.
The BP and HR were examined by sphygmomanometer
(HEM-6200, OMRON, China). SaO2 was measured by
Pulse Oximeter (NONIN-9550, Nonin Onyx, America).
All of the questionnaires and measurements were
non-invasive. All of the trial procedures were performed
at 500 m within one week before ascending in Chengdu
and within 24 h after arrival at 3700 m (Lhasa, around
13:00 pm from June 21st-25th, 2012 and examinations
were performed around 8:00–11:00 am in the next
morning upon arrival. The minimal and the maximal
time from arrival to the examination were 19 hours and
22 hours respectively). The subjects stayed at 3700 m for
a week before leaving for the next work place.
Statistical analysis
The CRFs were rejected if the demographic information,
BP, SaO2 and HR, were not completed.
Normally distributed variables were expressed as the
means ± standard deviations (SD), while the non-normally
distributed variables were expressed as medians (inter-
quartile ranges). Independent T tests were used to
compare two means of normally distributed variables
between HAH+ and HAH- groups at 3700 m. Comparisons
of the above-mentioned parameters between 500 m and
3700 m altitude were employed by paired-sample T tests.
The Mann–Whitney U-test was applied to evaluate
differences between ordinal or non-normally distributed
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if p < 0.05. A variable with p < 0.05 was considered a
potential risk factor in preliminary screening, and the
variable was subjected to an adjusted binary logistic
regression model to identify the adjusted independent risk
factors for HAH through backward stepwise regression.
The statistical analyses were performed using SPSS
19.0 for Windows. Statisticians from Third Military
Medical University reviewed all of the statistical methods
and results.
Results
We collected 793 (excluding 34 lost follow-up and 23
uncompleted CRFs) valid CRFs at both 500 m and 3700 m.
The mean age of the subjects was 23.03 ± 4.01 years old
(mean ± SD), and the mean BMI was 21.86 ± 2.76 kg/m2.
Percentage of smoking was 74.3% (589/793, including
historical and present of smoking) while percentage of
drinking 63.8% (506/793, including past and present
drinking). The racial composition of the population was
mostly Chinese Han (85.8%). The reported percentage of
insomnia at 500 m was 14.5% (115 out of 793).
Of all participants, 73.3% experienced HAH upon acute
exposure at 3700 m. Physiological and psychological
parameters with statistical differences from 500 m to
3700 m were summarized in Table 1, including systolic
blood pressure (SBP), diastolic blood pressure (DBP),
mean arterial blood pressure (MAP), HR, pulse pressure
(ΔBP) SaO2, SAS, and ESS (all of the p-value <0.001).
Percentages of primary headache history (p <0.001) and
insomnia (p <0.001) were significantly higher in HAH+
group than HAH- group (Table 2). Mean age was higher
in HAH+ group than HAH- group (p =0.011). HAH+
subjects with a higher HR (p =0.002), SAS (p <0.001) and
ESS (p <0.001) but a lower SaO2 (p =0.001) than
HAH- subjects. PLI was also significantly different
between HAH+ and HAH- groups (p =0.044) (Table 2).Table 1 Physiological and psychological parameters at
500 m and 3700 m
500 m 3700 m Change p value
SBP 115.23±10.51 119.03±12.16 10.65±8.32 <0.001
DBP 72.71±9.29 78.90±10.20 10.30± <0.001
ΔBP 43.52±7.73 40.13±8.06 8.33±7.59 <0.001
MAP 86.82±9.06 92.27±10.20 9.81±8.02 <0.001
SaO2 98.09±1.03 88.77±3.16 9.34±3.21 <0.001
HR 65.92±10.40 84.81±12.55 20.06±11.80 <0.001
SAS 21(3) 24(6) 7(10) <0.001
ESS 11(4) 12(5) 2(4) <0.001
SBP, DBP, MAP and ΔBP: mmHg; SaO2:%; HR: beat per min (bpm); SAS and
ESS: score; bracket: inter-quartile range. Comparison of SBP, DBP, MAP, ΔBP,
SaO2 and HR were employed by paired-sample T test between 500 m and
3700 m altitude. SAS and ESS were compared by Mann–Whitney U-test.The abovementioned factors were selected into preliminary
screening of the logistic regression model for each
single variable.
People with insomnia had higher rate of HAH than
those without insomnia (80.5% vs. 60.0%, p <0.001).
Individuals with a history of primary headache reported
more HAH than those without a primary history (91.2% vs.
69.3%, p <0.001).
The severity of HAH was related to age (r =0.073,
p =0.039), HR (r =0.122, p =0.001), SaO2 (r =−0.144,
p <0.001), SAS (r =0.360, p <0.001) and ESS (r =0.186,
p <0.001).
Each single variable was analyzed by logistic regression
in the preliminary screening. Age, primary headache
history, SAS, SaO2, HR, insomnia, ESS and PLI were
included in the next analysis for independent risk factors
(all of the p-value <0.05). However, the variables below
were not used in the next adjusted logistic regression
models due to the p >0.05, including BMI, smoking
history, alcohol consumption history, previous high
altitude exposure, athletic training, SBP, DBP, MAP and
ΔBP (Table 3).
Analysis by logistic regression revealed that the following
factors were the independent ones for HAH including
primary headache history (OR: 3.30; 95% CI: 1.73–6.30;
p <0.001), insomnia (OR: 1.91; 95% CI: 1.35–2.70; p <0.001),
low SaO2 (OR: 0.94; 95% CI: 0.89–1.00; p =0.035), high
HR (OR: 1.02; 95% CI: 1.01–1.03; p =0.009) and SAS
(OR: 1.18; 95% CI: 1.11–1.25; p <0.001). They were all
strongly associated with HAH (Table 3).Discussion
The stress of high-altitude hypobaric hypoxia may cause
the pathogenesis of HAH. As demonstrated herein,
occurrence of HAH was influenced by several factors.Relationship between HAH and anxiety after acute high
altitude exposure
High-altitude hypobaric hypoxia is a challenge to the
psychological state and physiological condition of human
beings. The association of cephalalgia with anxiety
disorders has also been indicated by several studies
[16]. However, the relationship between anxiety or
SAS and HAH is not confirmed. In our study, SAS would
reflect the extent of anxiety substantially in recent time at
high altitude though it was performed within 24 hours
after arrival at 3700 m. The SAS score which reflected
level of anxiety state was higher in HAH+ group than that
in HAH- groups. We observed that the high SAS score
was closely related to HAH (the median SAS score was 24
in HAH+ and 22 in HAH- subjects), even though few
subjects (5 cases) were confirmed to have an anxiety
disorder (SAS score>40). Thus, our findings together with
Table 2 Risk factors in various degrees of HAH
Headache Cases(n) HAH-(212) HAH+(581) HAH intensities p (HAH+ vs. HAH-)
1(487) 2(88) 3(6)
Demographic factors
Age 22.49±3.42 23.23±4.18 23.17±4.12 23.51±4.20 24.64±3.67 0.011
BMI 21.71±2.52 21.92±2.84 21.91±2.91 21.86±2.50 23.34±2.47 0.351
Smoking 0.740
0 43(20.3) 161(27.7) 139(28.5) 22(25.0) 0(0)
1 133(62.7) 287(49.4) 240(49.3) 43(48.9) 4(66.7)
2 36(17.0) 133(22.9) 108(22.2) 23(26.1) 2(33.3)
Alcohol consumption 0.748
0 72(34.0) 215(37.0) 182(37.4) 32(36.4) 1(16.7)
1 16(7.5) 26(4.5) 23(4.7) 3(3.4) 0(0)
2 124(58.5) 340(58.5) 282(57.9) 53(60.2) 5(83.3)
History
Primary headache(yes) 12(5.7) 124(21.3) 86(17.7) 34(38.6) 4(66.7) <0.001
High altitude exposure (yes) 64(30.2) 156(26.9) 127(26.1) 24(27.3) 5(83.3) 0.353
Athletic training(yes) 23(10.8) 72(12.4) 56(11.5) 16(18.2) 0(0) 0.554
PLI 0.044
1 45(21.2) 156(26.8) 132(27.1) 23(26.1) 1(16.7)
2 103(48.6) 284(48.9) 232(47.6) 49(55.7) 3(50.0)
3 64(30.2) 141(24.3) 123(25.3) 16(18.2) 2(33.3)
At 3700 m
Psychological scale
SAS 22(4) 24(6) 24(5) 27(10) 28.5(8.75) <0.001
Physiological factors
SBP 118.50±11.04 119.23±12.55 119.04±12.53 120.47±12.88 115.83±8.47 0.458
DBP 78.57±10.03 79.02±10.26 78.92±10.22 79.72±10.60 76.33±8.96 0.582
ΔBPBP 39.93±7.13 40.21±8.38 40.12±8.29 40.75±9.06 39.50±5.17 0.672
MAP 91.88±9.82 92.42±10.35 92.30±10.33 93.30±10.58 89.50±8.46 0.508
SaO2 89.41±2.74 88.54±3.27 88.67±3.24 87.82±3.38 87.83±3.06 0.001
HR 82.49±11.69 85.66±12.76 85.13±12.39 88.22±13.76 90.50±22.23 0.002
Sleep
Insomnia(yes) 95(44.8) 393(67.6) 312(64.1) 76(86.4) 5(83.3) <0.001
ESS 11(4.5) 12(5) 12(5) 14(5) 12(7.25) <0.001
Independent T tests were used to compare two means of SBP, DBP,ΔBP, MAP, SaO2, and HR between HAH+ and HAH- groups at 3700 m. The Mann–Whitney
U-test was applied to evaluate differences between ordinal or non-normally distributed data (PLI, smoking, alcohol consumption, SAS and ESS).
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stress could be used as predictors of headache.
Relationship between sleep and HAH at high altitude
There is a bidirectional relationship between sleep
disturbance and cephalalgia at low altitude [18]. A previous
study revealed that transient recurrent situational insomnia
was associated with headache [11]. On the other hand,
another research indicated that individuals with headache
were more likely to report insomnia[12]. Insomnia
increased the rate of HAH in our study, which isconsistent with the study that people with insomnia
have an increased risk of recurrent headache at low
altitude [12].
Lethargy is a common subjective complaint upon
high-altitude exposure. ESS is not only a subjective
measure of daytime sleepiness or sleep propensity but
also an evaluation for objective sleepiness [19,20].
Although it was significantly different between HAH+
and HAH- groups in our study, ESS score was not a
risk factor for HAH after adjusting for other factors, such
as anxiety.
Table 3 Logistic regression analysis for each single





(95% CI)a p value
Demographic factors
Age 0.05 1.05 1.01–1.10 0.020
BMI 0.03 1.03 0.97–1.09 0.352
Smoking 0.03 0.97 0.77–1.22 0.790
Alcohol consumption –0.04 0.96 0.82–1.14 0.680
History
Primary headache(yes) 1.51 4.52 2.44–8.37 <0.001
High altitude exposure (yes) –1.64 0.85 0.60–1.20 0.353
Athletic training(yes) 0.15 1.16 0.71–1.91 0.554
Psychological scale
SAS 0.20 1.22 1.16–1.29 <0.001
Physiological factors
SBP 0.01 1.01 0.99–1.02 0.457
DBP 0 1.00 0.99–1.02 0.581
ΔBPBP 0 1.00 0.98–1.02 0.671
MAP 0.01 1.00 0.99–1.02 0.507
SaO2 –0.09 0.91 0.86–0.96 0.001
HR 0.02 1.02 1.01–1.04 0.002
Sleep
Insomnia(yes) 0.97 2.64 1.92–3.65 <0.001
ESS 0.09 1.09 1.05–1.14 <0.001
PLI –0.23 0.80 0.64–1.00 0.045
Adjusted independent
risk factors
Primary headache history (yes) 1.20 3.30 1.73–6.30 <0.001
Insomnia(yes) 0.65 1.91 1.35–2.70 <0.001
SaO2 –0.06 0.94 0.89–1.00 0.035
HR 0.020 1.020 1.00–1.03 0.009
SAS 0.16 1.18 1.11–1.25 <0.001
a: 95% CI: 95% confidence intervals. A binary logistic regression model was
used to identify the risk factors for HAH.
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HAH caused insomnia at night, it is necessary to relieve
the symptoms of both HAH and insomnia. Before and
after arrival at high-altitude maintaining adequate sleep
and preventing HAH will be helpful.
History affecting the HAH development
History of primary headache is a risk factor of HAH in our
study, which is in agreement with that migraine increased
both the frequency and severity of HAH [21], but in
contrast to a study that migraine history did not affect
HAH [22]. The inconsistencies among these investigations
may be due to the variations of sample sizes, altitudes
and ascending speeds. Thus, research on headacheprovides a possible theoretical and methodological basis
for studying HAH.
We found that histories of high-altitude exposure and
athletic training were not risk factors for HAH, similar to
the report [10] that history of pre-exposure >2000 m was
not different between HAH+ and HAH- groups. Neither
history of high-altitude exposure nor athletic training is
closely associated with HAH, possibly due to the athletic
training intensity and period without conformity.HAH and cardiovascular system alternations
HR increased rapidly upon high-altitude (3700 m) exposure
and increased HAH in our study, similar to another
research on HAH risk factors in mountaineers [10].
In this study, SBP, DBP, MAP and ΔBP were not different
between HAH+ and HAH- groups. While augmented BP
may cause headache, a slight rise in BP does not trigger a
strong headache.
We also found that SaO2, an indicator of oxygen
supply to tissues and organs, was negatively correlated
to HAH due to desaturation of oxygen and hypoxia, a
finding consistent with a previous study [10]. Thus,
SaO2 is a protective determinant of HAH, which can
be improved by oxygen inhalation to prevent HAH
and AMS.Demographic factors and HAH
Age and BMI did not contribute to HAH in our study, a
similar outcome to that of other studies [10], possibly
because all subjects were healthy young men (23.03
±4.01 years old). However, age was related to the severity
of HAH. Subjects in HAH+ group were older than those
in HAH- one, which is contrary to another study [9].
BMI (21.86±2.76 kg/m2), which was concentrated in the
normal healthy range, was not closely related to HAH.
Our study did not reveal any associations between
HAH and cigarette or alcohol consumption. However,
smokers with high headache prevalence than non-smokers
at low altitude [23]. It has been indicated that alcohol
consumption reduces migraine [23]. Therefore, we sur-
mise that the response to acute altitude exposure through
vasoconstriction, change of cerebrovascular reactivity and
other physiological compensatory reactions disguised the
effect of smoking and alcohol consumption on headache,
and that the smoking and drinking indexes (or cumulative
amounts of smoking and drinking) did not affect HAH.
PLI was not an independent risk factor associated with
HAH, though it was significantly different between
HAH+ and HAH- groups. However, studies have found
that low physical activity is associated with the higher
prevalence of migraines [24]. Such contradiction may
be attributed to our non-precise quantitative physical
labor intensity.
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HAH was performed over a longer time period with a
wider height spectrum (from 2200 to 3817 m) [10],
where HAH may not be typical. Our study was performed
within 24 hours after arrival at 3700 m by plane within
two hours, giving them “acute altitude exposure”. Thus,
the homogeneity of our study is more representative.
Furthermore, we also included psychological risk factors
in our study.
Limitations
As Lawley et al. suggested that the researchers should not
label all headache as HAH just because their presence was
reported above 500 m [5], we screened headache that
occurred at high altitude. In this study, headache basically
satisfied the diagnostic criteria of the International
Classification of Headache Disorders, although headache
characteristics were not detailedly recorded in CRFs,
which should be improved in the future studies. Although
the descent was not performed immediately after the
onset of the headache, cephalalgia almost resolved after a
five days’ rest at 3700 m [25.6%, 153 out of 597 (mild: 143,
moderate: 9, severe: 1)]. In addition, there are many other
potential risk factors that have not been considered in this
study (such as family factors).
Conclusions
Insomnia is a risk factor for HAH, but high ESS is not,
which reveals the relationship between sleep and HAH.
History of primary headache is also a risk factor for
HAH. The physiological factors, low SaO2 and high HR
are related to a high probability of HAH. Additionally, a
high SAS score remains hazardous for HAH. Reducing
the risk factors may be approaches to decrease HAH
and protect individuals who ascend to high altitudes
acutely. However, demographic factors, such as age, are
not independent risk factor. Identification of the risk
factors for HAH provides information for the prevention
and treatment of HAH.
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